viernes, 1 de noviembre de 2024
Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies November 12, 2024
Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies
November 12, 2024
https://www.fda.gov/drugs/news-events-human-drugs/clinical-pharmacology-considerations-radiolabeled-mass-balance-studies-11122024?utm_medium=email&utm_source=govdelivery
NIST Announces 14 Candidates to Advance to the Second Round of the Additional Digital Signatures for the Post-Quantum Cryptography Standardization Process
NIST Announces 14 Candidates to Advance to the Second Round of the Additional Digital Signatures for the Post-Quantum Cryptography Standardization Process
NIST publishes NIST Internal Report (IR) 8528, Status Report on the First Round of the Additional Digital Signature Schemes for the NIST Post-Quantum Cryptography Standardization Process.
https://www.nist.gov/news-events/news/2024/10/nist-announces-14-candidates-advance-second-round-additional-digital
New Healthcare Quality Indicator from AHRQ Aimed at Addressing Maternal Morbidities
New Healthcare Quality Indicator from AHRQ Aimed at Addressing Maternal Morbidities: The U.S. has one of the highest maternal mortality rates in the world among wealthy nations, with an estimated 60,000 women affected each year by serious pregnancy-related complications. In response to this crisis, the United States has made improving maternal health—including maternal behavioral health—a national priority.
National Advisory Council Meeting Agenda - National Advisory Council Meeting Agenda November 20, 2024 11:00 am – 3:30 pm Eastern Time
National Advisory Council Meeting Agenda: Meeting AgendaSelect to view the meeting agenda (PDF, 166 KB)Zoom Webinar InstructionsPlease select for Zoom Webinar instructions.Note: Zoom will open 15 minutes in advance of the meeting. You are encouraged to sign in, in advance of the meeting.
Suscribirse a:
Entradas (Atom)